Clinical trial Recruiting at 1 site Observational Ages 18 to 120

Monitoring substance use and tracking relapse through smartphone data

Official title: SMART-r: Substance Monitoring and Active Relapse Tracking Repository

Run by National Institutes of Health Clinical Center (CC) · NCT06676059 · Data updated 2026-11-12

This study is testing a smartphone app to see how tracking people's phone use and habits can help understand and prevent drug and alcohol relapse in adults.

Quick facts

Study typeObservational
Ages18 Years to 120 Years
SexAll
Enrollment10000 (estimated)
SponsorNational Institutes of Health Clinical Center (CC)
NIH
Locations1 site (Baltimore, Maryland)
StatusRecruiting
StartedNovember 15, 2026
Main results expectedDecember 31, 2044
Study endsDecember 31, 2044
Registry record updatedNovember 10, 2026
Trial IDNCT06676059 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 or older who have used drugs or alcohol in the past 30 days and own an Android smartphone.

Probably not a fit

Patients who do not use drugs or alcohol or do not have an Android smartphone will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to create a comprehensive data repository by collecting survey and smartphone data from adults who have used drugs or alcohol. Participants will use the TTRU-Curtis AWARE app to provide digital phenotyping data, which includes smartphone usage, social media interactions, and sensor measurements. The goal is to analyze this data to uncover behavioral patterns and risk factors associated with substance use, ultimately informing prevention and intervention strategies. Data collection will occur over a period of up to six months, with all activities conducted online.

Why it matters

Potential benefit: If successful, this study could provide valuable insights that improve treatment outcomes for individuals struggling with substance use disorders.

How similar studies have gone: While the approach of using digital phenotyping for substance use research is emerging, similar studies have shown promise in understanding behavioral patterns and improving treatment strategies.

Who can join: the full rules

Show full inclusion / exclusion criteria
* INCLUSION CRITERIA:

In order to be eligible to participate in the repository, an individual must meet all of the following criteria:

* Must understand and be willing to complete an online informed consent process.
* Be an adult aged 18 or older.
* Self-report alcohol or other drug use within the past 30 days.
* Have a smartphone as their primary mobile phone.

  --For the AWARE app data monitoring procedure, there may be times during this study period where, due to technical or OS limitations, the app is only available to users of certain devices (e.g., Android, iOS). If there is such a limitation, this information will be evaluated during screening. For example, if the AWARE app is not available for iOS, then the screening form may exclude iPhone users for that time period where the limitation exists, if the only procedures offered are daily diary surveys and AWARE data monitoring.
* Be willing to adhere to the procedures, such as downloading the AWARE app onto their smartphone and keeping it active throughout the data collection period, completing baseline questionnaires, daily diary EMAs, open-ended survey questions with the TTR Chatbot, uploading historical conversational AI data, and/or follow-up surveys.
* Understand and write in English.

  --This exclusion criterion is included because future research on the data collected will include linguistic analysis. all linguistic analyses, we remove rare words (e.g., words must be said by at least 95% of participants)95. Additionally, there are cultural differences across languages and, thus, interpreting language results across more than one language becomes difficult.96 As a result, we must keep analysis limited to a single language (English), since words in other languages will not meet that criteria.
* Live in the United States.

EXCLUSION CRITERIA:

An individual who meets any of the following criteria will be excluded from participation in this repository:

1\. Any impairment severe enough to preclude informed consent or valid self-report.

Where it's running

  • National Institute on Drug Abuse
    Baltimore, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Brenda L Curtis, Ph.D. — National Institute on Drug Abuse (NIDA)
  • Study coordinator: Jessica E Hemmons
  • Email: jessie.hemmons@nih.gov
  • Phone: Not Listed

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.